Our facility in Morris Plains, New Jersey has been producing groundbreaking cell therapies for patients since 2015. The site specializes in advanced manufacturing and supply chain processes that ensure the timely delivery and efficacy of these innovative treatments at scale.
Key Facts About the Site
2015
1st
for immunocellular therapy production in the US
150K+
Featured Stories
Designing for the Future: The Next Era of Biomedical Research in San Diego
Thierry Diagana, California Sites Head at Novartis, shares the vision for a new research hub that will power future drug discovery.
Novartis in San Diego: A Quarter Century of R&D Innovation
A look back at a legacy of biomedical research breakthroughs that trace their roots to our San Diego site.
What's next in Neuroscience drug discovery
A Q&A with Bryan Laffitte, who leads a Novartis team that’s using the tools of genetic medicine to innovate new therapies for neuromuscular and neurodegenerative conditions.
